Showing results (91-100 of 176) with videos related to
Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry|December 13, 2006
3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipidsAgnes Kapou, Nikolas P Benetis, Nikos Avlonitis, et al.Molecules (Basel, Switzerland)|March 13, 2025
Spectroscopic Characterization Using <sup>1</sup>H and <sup>13</sup>C Nuclear Magnetic Resonance and Computational Analysis of the Complex of Donepezil with 2,6-Methyl-β-Cyclodextrin and Hydroxy Propyl Methyl CelluloseNikoletta Zoupanou, Paraskevi Papakyriakopoulou, Nikitas Georgiou, et al.Molecules (Basel, Switzerland)|April 23, 2022
Conformational Properties of New Thiosemicarbazone and Thiocarbohydrazone Derivatives and Their Possible TargetsNikitas Georgiou, Aikaterini Katsogiannou, Dimitrios Skourtis, et al.Biochimica Et Biophysica Acta|December 3, 2014
A novel synthetic luteinizing hormone-releasing hormone (LHRH) analogue coupled with modified β-cyclodextrin: insight into its intramolecular interactionsGolfo G Kordopati, Theodore V Tselios, Tahsin Kellici, et al.Carbohydrate Research|March 28, 2015
Branched-chain sugar nucleosides: stereocontrolled synthesis and bioevaluation of novel 3'-C-trifluoromethyl and 3'-C-methyl pyranonucleosidesNikolaos Kollatos, Stella Manta, Athina Dimopoulou, et al.Journal of Computer-Aided Molecular Design|July 13, 2010
An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT(1) angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studiesGeorge Agelis, Panagiota Roumelioti, Amalia Resvani, et al.Journal of Chemical Information and Modeling|February 28, 2018
Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding ModePanagiotis Lagarias, Eleni Vrontaki, George Lambrinidis, et al.Bioorganic & Medicinal Chemistry|August 3, 2016
Exploring new scaffolds for angiotensin II receptor antagonismEftichia Kritsi, Minos-Timotheos Matsoukas, Constantinos Potamitis, et al.Journal of Pharmaceutical and Biomedical Analysis|June 1, 2005
2D NMR and conformational analysis of a prototype anti-tumour steroidal esterAgnes Kapou, Manolis A Fousteris, Sotiris S Nikolaropoulos, et al.Molecules (Basel, Switzerland)|August 12, 2022
Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin SystemGraham J Moore, Harry Ridgway, Konstantinos Kelaidonis, et al.Pageof 18